KennethRobertCarsonMD, PhD, FACP

Oncology • Chicago, IL

Associate Professor, Hematology/Oncology, Northwestern University Feinberg School of Medicine

Join to view full profile

Dr. Carson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Carson's full profile

Already have an account?

Office
1725 W Harrison St
Ste 1010
Chicago, IL 60612
Phone+1 312-226-2371

Fax+1 312-942-9644
Is this information wrong?

Education & Training

McGaw Medical Center of Northwestern UniversityFellowship, Hematology and Medical Oncology, 2005 - 2008
Duke University HospitalResidency, Internal Medicine, 2000 - 2003
Keck School of Medicine of the University of Southern CaliforniaClass of 2000

Certifications & Licensure

IL State Medical License 2004 - 2026
MO State Medical License 2008 - 2024
NC State Medical License 2003 - 2005
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012

Clinical Trials

T-Cell Project: Prospective Collection of Data in Patients With Peripheral T-Cell Lymphoma Start of enrollment: 2006 Sep 01
Completed
Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma Start of enrollment: 2011 Oct 01
Completed
Phase 2
Phase I/II Study of Abraxane in Recurrent and Refractory Lymphoma Start of enrollment: 2012 Jul 01
Terminated
Phase 1
Study of KW-0761 Versus Vorinostat in Relapsed/Refractory CTCL Start of enrollment: 2012 Nov 01
Completed
Phase 3
Geriatric Assessments in Senior Adults With Multiple Myeloma Start of enrollment: 2012 Sep 01
Completed
VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Everolimus for Treating Patients With Pancreatic Neuroendocrine Tumors Start of enrollment: 2013 May 03
Terminated
Phase 1, Phase 2
Brentuximab Vedotin and Lenalidomide for Relapsed or Refractory Diffuse Large B-cell Lymphoma Start of enrollment: 2014 Sep 18
Completed
Phase 1
Phase I Study of Romidepsin, Gemcitabine, Oxaliplatin, and Dexamethasone in Patients With Relapsed/Refractory Aggressive Lymphomas Start of enrollment: 2015 Feb 04
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

3 citations
Characteristics and clinical outcomes of patients with ALK-positive anaplastic large cell lymphoma: Report from the prospective international T-cell lymphoma project.
Carlos Chiattone, Monica Civallero, Thais Fischer, Eliana Miranda, Martina Manni, Natalia P C Zing, Stefano A Pileri, Silvia Montoto, Steven M Horwitz, Maria Elena Cab...> ;Hematological Oncology. 2022 Dec 1
12 citations
Survival of veterans treated with enzalutamide and abiraterone for metastatic castrate resistant prostate cancer based on comorbid diseases.
Martin W Schoen, Kenneth R Carson, Seth A Eisen, Suhong Luo, Melissa A Reimers, Eric M Knoche, Alison L Whitmer, Yan Yan, Bettina F Drake, Kristen M Sanfilippo, Bennet...> ;Prostate Cancer and Prostatic Diseases. 2023 Dec 1
1 citations
Characteristics and Outcome of Extranodal NK/T-cell Lymphoma in North America: A Retrospective Multi-Institutional Experience.
N Nora Bennani, Aung M Tun, Kenneth R Carson, Jessica L Geiger, Lauren S Maeda, Kerry J Savage, Jim Rose, Lauren Pinter-Brown, Matthew A Lunning, Jeremy S Abramson, Na...> ;Clinical Lymphoma, Myeloma & Leukemia. 2022 May 1
Characteristics and Outcome of Extranodal NK/T-Cell Lymphoma in North America: A Retrospective Multi-Institutional Experience.
N Nora Bennani, Aung M Tun, Kenneth R Carson, Jessica L Geiger, Lauren S Maeda, Kerry J Savage, Jim Rose, Lauren Pinter-Brown, Matthew A Lunning, Jeremy S Abramson, Na...> ;Clinical Lymphoma, Myeloma & Leukemia. 2022 Apr 1
15 citations
Evaluation of the Khorana score for prediction of venous thromboembolism in patients with multiple myeloma.
Kristen M Sanfilippo, Kenneth R Carson, Tzu-Fei Wang, Suhong Luo, Natasha Edwin, Nicole Kuderer, Jesse M Keller, Brian F Gage> ;Research and Practice in Thrombosis and Haemostasis. 2022 Jan 1
18 citations
Real-World Data of Palbociclib in Combination With Endocrine Therapy for the Treatment of Metastatic Breast Cancer in Men.
Albert L. Kraus, Michelle Yu-Kite, Jack Mardekian, Matthew J. Cotter, Sindy T. Kim, Jaclyn Decembrino, Tamara Snow, Kenneth R. Carson, Jillian Motyl Rockland, Anala Go...> ;Clinical Pharmacology and Therapeutics. 2021 Oct 20
14 citations
Mogamulizumab efficacy is underscored by its associated rash that mimics cutaneous T-cell lymphoma: a retrospective single-centre case series
Nicholas A. Trum, Jasmine Zain, X. Martinez, Vishwas Parekh, Michelle Afkhami, Farah Abdulla, Kenneth R. Carson, Steven T. Rosen, Christiane Querfeld> ;The British Journal of Dermatology. 2021 Aug 24
1 citations
The First 2 Years of Biosimilar Epoetin for Cancer and Chemotherapy-Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions.
, , , , , , , , , , , , , , , , , , , , , > ;The Oncologist. 2021 Aug 1
Contemporary Clinical Trials Office: Doing More With Less.
Kenneth R. Carson> ;JCO Oncology Practice. 2021 Jan 1
77 citations
Prevalence of High Tumor Mutational Burden and Association With Survival in Patients With Less Common Solid Tumors.
Changxia Shao, Gerald Li, Lingkang Huang, Scott K. Pruitt, Emily Castellanos, Garrett M. Frampton, Kenneth R. Carson, Tamara Snow, Gaurav Singal, David Fabrizio, Brian...> ;JAMA Network Open. 2020 Oct 1
16 citations
Venous thromboembolism in multiple myeloma is associated with increased mortality.
Martin W. Schoen, Kenneth R. Carson, Suhong Luo, Brian F. Gage, Ang Li, Amber Afzal, Kristen M. Sanfilippo> ;Research and Practice in Thrombosis and Haemostasis. 2020 Sep 25
2 citations
End of an era of administering erythropoiesis stimulating agents among Veterans Administration cancer patients with chemotherapy-induced anemia.
, , , , , , , , , , , , , , , > ;Plos One. 2020 Jun 25
15 citations
Clinical and Genomic Characteristics of Small Cell Lung Cancer in Never Smokers: Results From a Retrospective Multicenter Cohort Study
Anish Thomas, Idrees Mian, Camille Tlemsani, Lorinc Pongor, Nobuyuki Takahashi, Kathleen Maignan, Jeremy Snider, Gerald Li, Garrett M. Frampton, Siraj M. Ali, Se Hyun ...> ;Chest. 2020 May 26
6 citations
Outcomes of Patients with Transformed Mycosis Fungoides: Analysis from a Prospective Multicenter US Cohort Study.
Frederick Lansigan, Steven M. Horwitz, Lauren C. Pinter-Brown, Kenneth R. Carson, Andrei R. Shustov, Steven T. Rosen, Barbara Pro, Eric D. Hsi, Massimo Federico, Chris...> ;Clinical Lymphoma, Myeloma & Leukemia. 2020 May 11
9 citations
Metformin Use and Pancreatic Cancer Survival among Non-Hispanic White and African American U.S. Veterans with Diabetes Mellitus.
Adetunji T. Toriola, Suhong Luo, Theodore S. Thomas, Bettina F. Drake, Su-Hsin Chang, Kristen M. Sanfilippo, Kenneth R. Carson> ;Cancer Epidemiology, Biomarkers & Prevention. 2020 Jan 1
11 citations
Advancing age and the risk of bleomycin pulmonary toxicity in a largely older cohort of patients with newly diagnosed Hodgkin Lymphoma
Theodore S. Thomas, Suhong Luo, Patrick M. Reagan, Jesse Keller, Kristen M. Sanfilippo, Kenneth R. Carson> ;Journal of Geriatric Oncology. 2020 Jan 1
16 citations
Splanchnic vein thrombosis predicts worse survival in patients with advanced pancreatic cancer
Amber Afzal, Luo Suhong, Brian F. Gage, Martin W. Schoen, Kenneth R. Carson, Theodore S. Thomas, Kristen M. Sanfilippo> ;Thrombosis Research. 2020 Jan 1
3 citations
Post-MGUS Diagnosis Serum Monoclonal-Protein Velocity and the Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma
Su-Hsin Chang, Jason Gumbel, Suhong Luo, Theodore S. Thomas, Kristen M. Sanfilippo, Jingqin Luo, Graham A. Colditz, Kenneth R. Carson> ;Cancer Epidemiology, Biomarkers & Prevention. 2019 Sep 9
94 citations
Predicting venous thromboembolism in multiple myeloma: development and validation of the IMPEDE VTE score
Kristen M. Sanfilippo, Suhong Luo, Tzu-Fei Wang, Mark A. Fiala, Martin W. Schoen, Tanya M. Wildes, Joseph Mikhael, Nicole M. Kuderer, Jesse Keller, Theodore S. Thomas,...> ;American Journal of Hematology. 2019 Nov 1
1 citations
Reflections on and future of hematologic malignancies research in the Veterans Health Administration.
Daphne R. Friedman, Kenneth R. Carson, J. Brice Weinberg> ;Seminars in Oncology. 2019 Aug 1
22 citations
Novel cell adhesion/migration pathways are predictive markers of HDAC inhibitor resistance in cutaneous T cell lymphoma.
Jared M. Andrews, Jennifer A. Schmidt, Kenneth R. Carson, Amy Musiek, Neha Mehta-Shah, Jacqueline E. Payton> ;Ebiomedicine. 2019 Aug 1
25 citations
Mogamulizumab-Associated Cutaneous Granulomatous Drug Eruption Mimicking Mycosis Fungoides but Possibly Indicating Durable Clinical Response
Lu Chen, Kenneth R. Carson, Karl Staser, Neha Mehta-Shah, Andras Schaffer, Ilana S. Rosman, Amy Musiek> ;JAMA Dermatology. 2019 Aug 1
88 citations
The role of autologous stem cell transplantation in patients with nodal peripheral T-cell lymphomas in first complete remission: Report from COMPLETE, a prospective, m...
Steven I. Park, Steven M. Horwitz, Francine M. Foss, Lauren C. Pinter-Brown, Kenneth R. Carson, Steven T. Rosen, Barbara Pro, Eric D. Hsi, Massimo Federico, Christian ...> ;Cancer. 2019 May 1
57 citations
Real-World Outcomes of Patients with Metastatic Non-Small Cell Lung Cancer Treated with Programmed Cell Death Protein 1 Inhibitors in the Year Following U.S. Regulator...
Sean Khozin, Kenneth R. Carson, Jizu Zhi, Melisa Tucker, Shannon E. Lee, David E. Light, Melissa D. Curtis, Marta Bralic, Irene Kaganman, Anala Gossai, Philip P. Hofme...> ;The Oncologist. 2019 May 1
18 citations
Disparities in the Use of Programmed Death 1 Immune Checkpoint Inhibitors.
Jeremy M. O’Connor, Kathi Seidl-Rathkopf, Aracelis Z. Torres, Paul You, Kenneth R. Carson, Joseph S. Ross, Cary P. Gross> ;The Oncologist. 2018 Nov 1
Join now to see all

Journal Articles

Prevalence of High Tumor Mutational Burden and Association with Survival in Patients with Less Common Solid Tumors
Kenneth Carson, MD, JAMA Network Open

Abstracts/Posters

Machine Learning Based Predictive Model of 5-Year Survival in Multiple Myeloma Autologous Transplant Patients
Kenneth R. Carson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Real-World Application of National Comprehensive Cancer Network (NCCN) Testing Guidelines in Diffuse Large B-Cell Lymphoma (DLBCL) Results in Underdiagnosis of Double-...
Kenneth R. Carson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Outcomes in Multiple Myeloma Based on Comorbidities and Race
Kenneth R. Carson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Approximating International Myeloma Working Group Uniform Response Criteria to Derive Response for Multiple Myeloma (MM) Patients Using Data from Electronic Health Rec...
Kenneth R. Carson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Romidepsin in Combination with Gemcitabine, Oxaliplatin, and Dexamethasone Shows Durable Responses in Aggressive Lymphomas
Kenneth R. Carson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Cell of Origin (COO) Association with High Body Mass Index (BMI) and Overall Survival (OS) in Patients with Diffuse Large B-Cell Lymphoma (DLBCL)
Kenneth R. Carson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Join now to see all

Lectures

Predicting Risk of Venous Thromboembolism in Multiple Myeloma: The Impede VTE Score
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Hepatitis B Testing Rates in Patients with Chronic Lymphocytic Leukemia before and during Administration of Anti-CD20 Therapy
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018